122 related articles for article (PubMed ID: 23059790)
1. No beneficial effect of intrathecal methylprednisolone acetate in postherpetic neuralgia patients.
Rijsdijk M; van Wijck AJ; Meulenhoff PC; Kavelaars A; van der Tweel I; Kalkman CJ
Eur J Pain; 2013 May; 17(5):714-23. PubMed ID: 23059790
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal methylprednisolone for intractable postherpetic neuralgia.
Kotani N; Kushikata T; Hashimoto H; Kimura F; Muraoka M; Yodono M; Asai M; Matsuki A
N Engl J Med; 2000 Nov; 343(21):1514-9. PubMed ID: 11087880
[TBL] [Abstract][Full Text] [Related]
3. Safety assessment and pharmacokinetics of intrathecal methylprednisolone acetate in dogs.
Rijsdijk M; van Wijck AJ; Kalkman CJ; Meulenhoff PC; Grafe MR; Steinauer J; Yaksh TL
Anesthesiology; 2012 Jan; 116(1):170-81. PubMed ID: 22139590
[TBL] [Abstract][Full Text] [Related]
4. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of intrathecal midazolam with or without epidural methylprednisolone for management of post-herpetic neuralgia involving lumbosacral dermatomes.
Dureja GP; Usmani H; Khan M; Tahseen M; Jamal A
Pain Physician; 2010; 13(3):213-21. PubMed ID: 20495585
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of cerebrospinal fluid before and after intrathecal injection of steroid into patients with postherpetic pain.
Lu J; Katano T; Nishimura W; Fujiwara S; Miyazaki S; Okasaki I; Aritake K; Urade Y; Minami T; Ito S
Proteomics; 2012 Oct; 12(19-20):3105-12. PubMed ID: 22936653
[TBL] [Abstract][Full Text] [Related]
7. Comparative therapeutic evaluation of intrathecal versus epidural methylprednisolone for long-term analgesia in patients with intractable postherpetic neuralgia.
Kikuchi A; Kotani N; Sato T; Takamura K; Sakai I; Matsuki A
Reg Anesth Pain Med; 1999; 24(4):287-93. PubMed ID: 10445766
[TBL] [Abstract][Full Text] [Related]
8. The safety and efficacy of KAI-1678- an inhibitor of epsilon protein kinase C (εPKC)-versus lidocaine and placebo for the treatment of postherpetic neuralgia: a crossover study design.
Cousins MJ; Pickthorn K; Huang S; Critchley L; Bell G
Pain Med; 2013 Apr; 14(4):533-40. PubMed ID: 23438341
[TBL] [Abstract][Full Text] [Related]
9. Lidocaine eye drops attenuate pain associated with ophthalmic postherpetic neuralgia.
Kanai A; Okamoto T; Suzuki K; Niki Y; Okamoto H
Anesth Analg; 2010 May; 110(5):1457-60. PubMed ID: 20237042
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgia.
Sabatowski R; Hans G; Tacken I; Kapanadze S; Buchheister B; Baron R
Curr Med Res Opin; 2012 Aug; 28(8):1337-46. PubMed ID: 22769236
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Curr Med Res Opin; 2009 Jul; 25(7):1677-87. PubMed ID: 19480610
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness of repetitive paravertebral injections with local anesthetics and steroids for the prevention of postherpetic neuralgia in patients with acute herpes zoster.
Ji G; Niu J; Shi Y; Hou L; Lu Y; Xiong L
Anesth Analg; 2009 Nov; 109(5):1651-5. PubMed ID: 19713253
[TBL] [Abstract][Full Text] [Related]
13. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ
J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a metered-dose 8% lidocaine pump spray for patients with post-herpetic neuralgia.
Kanai A; Kumaki C; Niki Y; Suzuki A; Tazawa T; Okamoto H
Pain Med; 2009; 10(5):902-9. PubMed ID: 19682274
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of local infiltration of triamcinolone acetonide with lignocaine compared with lignocaine alone in the treatment of postherpetic neuralgia.
Amjad M; Mashhood AA
J Coll Physicians Surg Pak; 2005 Nov; 15(11):683-5. PubMed ID: 16300701
[TBL] [Abstract][Full Text] [Related]
16. Review of current guidelines on the care of postherpetic neuralgia.
Argoff CE
Postgrad Med; 2011 Sep; 123(5):134-42. PubMed ID: 21904096
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster.
Wilhelm IR; Tzabazis A; Likar R; Sittl R; Griessinger N
Eur J Anaesthesiol; 2010 Feb; 27(2):169-73. PubMed ID: 20010108
[TBL] [Abstract][Full Text] [Related]
18. 5% lidocaine medicated plaster in elderly patients with postherpetic neuralgia: results of a compassionate use programme in France.
Clère F; Delorme-Morin C; George B; Navez M; Rioult B; Tiberghien-Chatelain F; Ganry H
Drugs Aging; 2011 Sep; 28(9):693-702. PubMed ID: 21913735
[TBL] [Abstract][Full Text] [Related]
19. Enhancing the relative safety of intentional or unintentional intrathecal methylprednisolone administration by removing polyethylene glycol.
Candido KD; Knezevic I; Mukalel J; Knezevic NN
Anesth Analg; 2011 Dec; 113(6):1487-9. PubMed ID: 21965368
[TBL] [Abstract][Full Text] [Related]
20. Comparing healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% versus gabapentin or pregabalin.
Kirson NY; Ivanova JI; Birnbaum HG; Wei R; Kantor E; Puenpatom RA; Ben-Joseph RH; Summers KH
J Med Econ; 2010; 13(3):482-91. PubMed ID: 20684669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]